Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:51 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4CompletedINTERVENTIONAL

Effect of hCG on Receptivity of the Human Endometrium

ClinicalTrials.gov · NCT01786252 · Registry updated: 2017-02-24

Condition / research focus: Infertility; Subfertility
Sponsor: Michigan State University
Countries with listed sites: United States
Registry dates and results: Start: 2013-01. Completion: 2016-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin (hCG) (drug) — also listed as: Novarel, human chorionic gonadotropin
Placebo Comparator (for hCG) (drug) — also listed as: IVF media, "Global" media-trademark

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The Fertility Center , 3230 Eagle Park Drive NE, suite 100
Grand Rapids, Michigan, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Human Chorionic Gonadotrophin & Trigger

ClinicalTrials.gov · NCT02264847 · Registry updated: 2017-02-08

Condition / research focus: Ovulation Disorder
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-10. Completion: 2017-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotrophin (drug) — also listed as: hCG
clomiphene citrate alone (drug)

Where the study takes place — 1 listed sites

faculty of medicine , Cairo University
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis

ClinicalTrials.gov · NCT02470169 · Registry updated: 2017-01-23

Condition / research focus: Subfertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
IUI (procedure)
Choriomon (drug)
shepherd catheter (device)
Ovulation detection (procedure)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

ClinicalTrials.gov · NCT02825290 · Registry updated: 2016-12-13

Condition / research focus: Embryo Transfer; Luteal Support
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-07. Completion: 2017-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Choriogonadotropin alfa (drug) — also listed as: recombinant hCG, Ovitrelle, Ovidrel
Triptorelin acetate (drug) — also listed as: GnRH-Agonist, Decapeptyl

Where the study takes place — 1 listed sites

Sheba medical center
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effects of SNP of GnRH Receptor Genes in IVF Patients

ClinicalTrials.gov · NCT02979886 · Registry updated: 2016-12-05

Condition / research focus: Infertility, Female
Sponsor: Miao benyu
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-01. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH-a (drug) — also listed as: triptorelin
Human Menopausal Gonadotropins (drug) — also listed as: menopur

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response

ClinicalTrials.gov · NCT02940535 · Registry updated: 2016-10-21

Condition / research focus: Subfertility, Female; Ovulation Disorder
Sponsor: Navy General Hospital, Beijing
Countries with listed sites: China
Registry dates and results: Start: 2016-12. Completion: 2020-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Diphereline (Triptorelin embonate) (drug)
Decapeptyl (Triptorelin) (drug)
human menopausal gonadotropin (drug)
human chorionic gonadotropin (drug)

Where the study takes place — 1 listed sites

Navy General Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?

ClinicalTrials.gov · NCT02371486 · Registry updated: 2016-10-14

Condition / research focus: Infertility; Complications; Cesarean Section
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-04. Completion: 2018-02 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hysteroscopic repair of cesarean section defect (procedure) — also listed as: hysteroscopic metroplasty, niche repair
Diagnostic Hysteroscopy (procedure)
Ultrasound Scan (procedure) — also listed as: Internal ultrasound
IVF Cycle (procedure) — also listed as: IVF Treatment

Where the study takes place — 1 listed sites

The chaim sheba medical center,Tel Hashomer
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism

ClinicalTrials.gov · NCT02880280 · Registry updated: 2016-08-26

Condition / research focus: Kallmann Syndrome; Hypogonadotropic Hypogonadism
Sponsor: Beijing Children's Hospital
Countries with listed sites: China
Registry dates and results: Start: 2016-08. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Menopausal Gonadotropin (drug) — also listed as: Human Menopausal Gonadotropin(hMG)
Human Chorionic Gonadotropin (drug) — also listed as: Human Chorionic Gonadotropin(hCG)

Where the study takes place — 1 listed sites

Beijing Children's Hospital
Beijing, Beijing Municipality, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Extending the hCG OPU Interval

ClinicalTrials.gov · NCT02871154 · Registry updated: 2016-08-18

Condition / research focus: Infertility
Sponsor: The Baruch Padeh Medical Center, Poriya
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-01. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Delaying oocyte pick up beyond 39 hours post hCG (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Low-dose Gonal-f® in Ovulation Induction

ClinicalTrials.gov · NCT01871532 · Registry updated: 2016-08-11

Condition / research focus: Infertility; Monofollicular Development
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Ireland · United Kingdom
Registry dates and results: Start: 2013-07. Completion: 2014-11 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonal-f® (drug) — also listed as: Recombinant follicle stimulating hormone (r-FSH)

Where the study takes place — 10 listed sites

Research Site
Cork, Ireland
Site recruitment: Not reported
Research Site
Dublin, Ireland
Site recruitment: Not reported
Research Site
Galway, Ireland
Site recruitment: Not reported
Research Site
Cambridge, United Kingdom
Site recruitment: Not reported
Research site
Cheshunt, United Kingdom
Site recruitment: Not reported
Research Site
Derby, United Kingdom
Site recruitment: Not reported
Research Site
Edinburgh, United Kingdom
Site recruitment: Not reported
Research Site
Glasgow, United Kingdom
Site recruitment: Not reported
Research site
London, United Kingdom
Site recruitment: Not reported
Research Site
Nottingham, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles

ClinicalTrials.gov · NCT02862782 · Registry updated: 2016-08-11

Condition / research focus: In-vitro Fertilization
Sponsor: Tel-Aviv Sourasky Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-09. Completion: 2019-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (Ovitrelle 250 mcg mcg - Merck Serono) (drug)
hCG (Ovitrelle 250 mcg mcg - Merck Serono) + GnRH agonist (Decapeptyl 0.2mg - Ferring Gmgh) (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia

ClinicalTrials.gov · NCT02544191 · Registry updated: 2016-08-02

Condition / research focus: Azoospermia
Sponsor: Jinling Hospital, China
Countries with listed sites: China
Registry dates and results: Start: 2015-12. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRHa/ hCG/ hMG (drug) — also listed as: Goserelin/ Pregnyl/ Urofollitropin for Injection

Where the study takes place — 1 listed sites

Center for Reproductive Medicine, Jinling Hospital
Nanjing, Jiangsu, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility

ClinicalTrials.gov · NCT02461173 · Registry updated: 2016-07-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
IUI (procedure)
Ovulation detection (procedure)
Choriomon (drug)
shepherd catheter (device)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Letrozole in Assisted Reproductive Technology

ClinicalTrials.gov · NCT02429999 · Registry updated: 2016-07-15

Condition / research focus: to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-04. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrezole plus FSH (drug)
Standard protocol for induction of ovulation (drug)

Where the study takes place — 1 listed sites

of Medicine
Asyut, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

ClinicalTrials.gov · NCT02827656 · Registry updated: 2016-07-12

Condition / research focus: Infertility
Sponsor: Meir Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-08. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Decapeptyl (drug)
hCG luteal support (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy

ClinicalTrials.gov · NCT02349945 · Registry updated: 2016-07-12

Condition / research focus: Male Infertility
Sponsor: Azienda USL Modena
Countries with listed sites: Germany · Italy
Registry dates and results: Start: 2011-01. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

follitropin alpha (drug) — also listed as: Gonal f

Where the study takes place — 6 listed sites

Zentrums für Reproduktions-medizin und Andrologie Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg
Halle, Germany
Site recruitment: Not reported
Dipartimento di Ginecologia e Medicina della Riproduzione IRCCS Istituto Clinico Humanitas,
Rozzano, Milan, Italy
Site recruitment: Not reported
Andrology Unit Department of Clinical Physiopathology
Florence, Italy
Site recruitment: Not reported
AziendaUSLModena
Modena, Italy
Site recruitment: Not reported
University of Padova Department of Histology, Microbiology and Medical Biotechnologies Clinical Pathology Section & Centre for Male Gamete Cryopreservation
Padova, Italy
Site recruitment: Not reported
Department of Medical Pathophysiology, University of Rome La Sapienza, Lab of Seminology & Immunology of Reproduction
Rome, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Dual Triggering in Patients With a High Immature Oocyte Rate

ClinicalTrials.gov · NCT02813239 · Registry updated: 2016-06-24

Condition / research focus: INFERTILITY
Sponsor: IVI Madrid
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-11. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (other) — also listed as: OVITRELLE (Merck Serono)
hCG + GnRH agonist (other) — also listed as: Ovitrelle (Merck Serono) + Decapeptyl (Ipsen Pharma)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Human Chorionic Gonadotropin Stimulation Effects on Steroidogenesis in Men With Klinefelter Syndrome

ClinicalTrials.gov · NCT02788136 · Registry updated: 2016-06-07

Condition / research focus: Steroidogenesis; Klinefelter Syndrome; Human Chorionic Gonadotropin (hCG) Stimulation
Sponsor: Azienda USL Modena
Countries with listed sites: Italy
Registry dates and results: Start: 2012-02. Completion: 2014-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin (drug) — also listed as: hCG

Where the study takes place — 1 listed sites

AziendaUSLModena
Modena, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

ClinicalTrials.gov · NCT01979341 · Registry updated: 2016-05-26

Condition / research focus: Pregnancy; Ovarian Hyperstimulation Syndrome
Sponsor: Antalya IVF
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2013-10. Completion: 2016-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

final oocyte maturation trigger (procedure) — also listed as: dual trigger: 6500 IU Ovitrelle (hCG) plus 0.2mg triptorelin acetate (GnRH agonist), hCG trigger: 6500 IU Ovitrelle (hCG), agonist trigger: 0.2mg triptorelin acetate (GnRH agonist)

Where the study takes place — 1 listed sites

Antalya IVF
Antalya, Antalya, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility

ClinicalTrials.gov · NCT02739516 · Registry updated: 2016-05-19

Condition / research focus: Unexplained Infertility
Sponsor: Benha University
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-06. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotropin (drug)
FSH co-trigger (drug)
Letrozole (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:51 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4CompletedINTERVENTIONAL

Effect of hCG on Receptivity of the Human Endometrium

ClinicalTrials.gov · NCT01786252 · Registry updated: 2017-02-24

Condition / research focus: Infertility; Subfertility
Sponsor: Michigan State University
Countries with listed sites: United States
Registry dates and results: Start: 2013-01. Completion: 2016-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin (hCG) (drug) — also listed as: Novarel, human chorionic gonadotropin
Placebo Comparator (for hCG) (drug) — also listed as: IVF media, "Global" media-trademark

Where the study takes place — 1 listed sites

The Fertility Center , 3230 Eagle Park Drive NE, suite 100
Grand Rapids, Michigan, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Human Chorionic Gonadotrophin & Trigger

ClinicalTrials.gov · NCT02264847 · Registry updated: 2017-02-08

Condition / research focus: Ovulation Disorder
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-10. Completion: 2017-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotrophin (drug) — also listed as: hCG
clomiphene citrate alone (drug)

Where the study takes place — 1 listed sites

faculty of medicine , Cairo University
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis

ClinicalTrials.gov · NCT02470169 · Registry updated: 2017-01-23

Condition / research focus: Subfertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
IUI (procedure)
Choriomon (drug)
shepherd catheter (device)
Ovulation detection (procedure)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

ClinicalTrials.gov · NCT02825290 · Registry updated: 2016-12-13

Condition / research focus: Embryo Transfer; Luteal Support
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-07. Completion: 2017-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Choriogonadotropin alfa (drug) — also listed as: recombinant hCG, Ovitrelle, Ovidrel
Triptorelin acetate (drug) — also listed as: GnRH-Agonist, Decapeptyl

Where the study takes place — 1 listed sites

Sheba medical center
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effects of SNP of GnRH Receptor Genes in IVF Patients

ClinicalTrials.gov · NCT02979886 · Registry updated: 2016-12-05

Condition / research focus: Infertility, Female
Sponsor: Miao benyu
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-01. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH-a (drug) — also listed as: triptorelin
Human Menopausal Gonadotropins (drug) — also listed as: menopur

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response

ClinicalTrials.gov · NCT02940535 · Registry updated: 2016-10-21

Condition / research focus: Subfertility, Female; Ovulation Disorder
Sponsor: Navy General Hospital, Beijing
Countries with listed sites: China
Registry dates and results: Start: 2016-12. Completion: 2020-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Diphereline (Triptorelin embonate) (drug)
Decapeptyl (Triptorelin) (drug)
human menopausal gonadotropin (drug)
human chorionic gonadotropin (drug)

Where the study takes place — 1 listed sites

Navy General Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?

ClinicalTrials.gov · NCT02371486 · Registry updated: 2016-10-14

Condition / research focus: Infertility; Complications; Cesarean Section
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-04. Completion: 2018-02 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hysteroscopic repair of cesarean section defect (procedure) — also listed as: hysteroscopic metroplasty, niche repair
Diagnostic Hysteroscopy (procedure)
Ultrasound Scan (procedure) — also listed as: Internal ultrasound
IVF Cycle (procedure) — also listed as: IVF Treatment

Where the study takes place — 1 listed sites

The chaim sheba medical center,Tel Hashomer
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism

ClinicalTrials.gov · NCT02880280 · Registry updated: 2016-08-26

Condition / research focus: Kallmann Syndrome; Hypogonadotropic Hypogonadism
Sponsor: Beijing Children's Hospital
Countries with listed sites: China
Registry dates and results: Start: 2016-08. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Menopausal Gonadotropin (drug) — also listed as: Human Menopausal Gonadotropin(hMG)
Human Chorionic Gonadotropin (drug) — also listed as: Human Chorionic Gonadotropin(hCG)

Where the study takes place — 1 listed sites

Beijing Children's Hospital
Beijing, Beijing Municipality, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Extending the hCG OPU Interval

ClinicalTrials.gov · NCT02871154 · Registry updated: 2016-08-18

Condition / research focus: Infertility
Sponsor: The Baruch Padeh Medical Center, Poriya
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-01. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Delaying oocyte pick up beyond 39 hours post hCG (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Low-dose Gonal-f® in Ovulation Induction

ClinicalTrials.gov · NCT01871532 · Registry updated: 2016-08-11

Condition / research focus: Infertility; Monofollicular Development
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Ireland · United Kingdom
Registry dates and results: Start: 2013-07. Completion: 2014-11 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonal-f® (drug) — also listed as: Recombinant follicle stimulating hormone (r-FSH)

Where the study takes place — 10 listed sites

Research Site
Cork, Ireland
Site recruitment: Not reported
Research Site
Dublin, Ireland
Site recruitment: Not reported
Research Site
Galway, Ireland
Site recruitment: Not reported
Research Site
Cambridge, United Kingdom
Site recruitment: Not reported
Research site
Cheshunt, United Kingdom
Site recruitment: Not reported
Research Site
Derby, United Kingdom
Site recruitment: Not reported
Research Site
Edinburgh, United Kingdom
Site recruitment: Not reported
Research Site
Glasgow, United Kingdom
Site recruitment: Not reported
Research site
London, United Kingdom
Site recruitment: Not reported
Research Site
Nottingham, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles

ClinicalTrials.gov · NCT02862782 · Registry updated: 2016-08-11

Condition / research focus: In-vitro Fertilization
Sponsor: Tel-Aviv Sourasky Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-09. Completion: 2019-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (Ovitrelle 250 mcg mcg - Merck Serono) (drug)
hCG (Ovitrelle 250 mcg mcg - Merck Serono) + GnRH agonist (Decapeptyl 0.2mg - Ferring Gmgh) (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia

ClinicalTrials.gov · NCT02544191 · Registry updated: 2016-08-02

Condition / research focus: Azoospermia
Sponsor: Jinling Hospital, China
Countries with listed sites: China
Registry dates and results: Start: 2015-12. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRHa/ hCG/ hMG (drug) — also listed as: Goserelin/ Pregnyl/ Urofollitropin for Injection

Where the study takes place — 1 listed sites

Center for Reproductive Medicine, Jinling Hospital
Nanjing, Jiangsu, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility

ClinicalTrials.gov · NCT02461173 · Registry updated: 2016-07-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
IUI (procedure)
Ovulation detection (procedure)
Choriomon (drug)
shepherd catheter (device)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Letrozole in Assisted Reproductive Technology

ClinicalTrials.gov · NCT02429999 · Registry updated: 2016-07-15

Condition / research focus: to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-04. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrezole plus FSH (drug)
Standard protocol for induction of ovulation (drug)

Where the study takes place — 1 listed sites

of Medicine
Asyut, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

ClinicalTrials.gov · NCT02827656 · Registry updated: 2016-07-12

Condition / research focus: Infertility
Sponsor: Meir Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-08. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Decapeptyl (drug)
hCG luteal support (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy

ClinicalTrials.gov · NCT02349945 · Registry updated: 2016-07-12

Condition / research focus: Male Infertility
Sponsor: Azienda USL Modena
Countries with listed sites: Germany · Italy
Registry dates and results: Start: 2011-01. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

follitropin alpha (drug) — also listed as: Gonal f

Where the study takes place — 6 listed sites

Zentrums für Reproduktions-medizin und Andrologie Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg
Halle, Germany
Site recruitment: Not reported
Dipartimento di Ginecologia e Medicina della Riproduzione IRCCS Istituto Clinico Humanitas,
Rozzano, Milan, Italy
Site recruitment: Not reported
Andrology Unit Department of Clinical Physiopathology
Florence, Italy
Site recruitment: Not reported
AziendaUSLModena
Modena, Italy
Site recruitment: Not reported
University of Padova Department of Histology, Microbiology and Medical Biotechnologies Clinical Pathology Section & Centre for Male Gamete Cryopreservation
Padova, Italy
Site recruitment: Not reported
Department of Medical Pathophysiology, University of Rome La Sapienza, Lab of Seminology & Immunology of Reproduction
Rome, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Dual Triggering in Patients With a High Immature Oocyte Rate

ClinicalTrials.gov · NCT02813239 · Registry updated: 2016-06-24

Condition / research focus: INFERTILITY
Sponsor: IVI Madrid
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-11. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (other) — also listed as: OVITRELLE (Merck Serono)
hCG + GnRH agonist (other) — also listed as: Ovitrelle (Merck Serono) + Decapeptyl (Ipsen Pharma)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Human Chorionic Gonadotropin Stimulation Effects on Steroidogenesis in Men With Klinefelter Syndrome

ClinicalTrials.gov · NCT02788136 · Registry updated: 2016-06-07

Condition / research focus: Steroidogenesis; Klinefelter Syndrome; Human Chorionic Gonadotropin (hCG) Stimulation
Sponsor: Azienda USL Modena
Countries with listed sites: Italy
Registry dates and results: Start: 2012-02. Completion: 2014-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin (drug) — also listed as: hCG

Where the study takes place — 1 listed sites

AziendaUSLModena
Modena, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

ClinicalTrials.gov · NCT01979341 · Registry updated: 2016-05-26

Condition / research focus: Pregnancy; Ovarian Hyperstimulation Syndrome
Sponsor: Antalya IVF
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2013-10. Completion: 2016-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

final oocyte maturation trigger (procedure) — also listed as: dual trigger: 6500 IU Ovitrelle (hCG) plus 0.2mg triptorelin acetate (GnRH agonist), hCG trigger: 6500 IU Ovitrelle (hCG), agonist trigger: 0.2mg triptorelin acetate (GnRH agonist)

Where the study takes place — 1 listed sites

Antalya IVF
Antalya, Antalya, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility

ClinicalTrials.gov · NCT02739516 · Registry updated: 2016-05-19

Condition / research focus: Unexplained Infertility
Sponsor: Benha University
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-06. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotropin (drug)
FSH co-trigger (drug)
Letrozole (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →